Loading
Loading…
Loading…
| # | Company | Amount | Rank | Status |
|---|---|---|---|---|
| 1 | L1₹26.3 LAdmitted-Fee/PreQual/Technical/Finance E49 5 2ND FLOOR OKHLA INDUSTRIAL AREA PHASE 2 DELHI DELHI 110020 | SOUTH EAST DELHI | DELHI | 110020 | ₹26.3 L | L1 | Admitted-Fee/PreQual/Technical/Finance |
| Sl No | Description | Qty | Unit | Premas Life Sciences Pvt. Ltd L1 |
|---|---|---|---|---|
| 1.00Supply of the following material: | ||||
| 1.01 | Illumina 5-Base DNA Prep with NovaSeqX 25B (48 Samples) | 1 | Nos. | 18,10,129 ₹19,09,686.1 Lowest |
| 1.02 | Illumina® 5-Base DNA Prep (24 Samples) | 2 | Nos. | 3,10,562 ₹6,55,285.82 Lowest |
| 1.03 | ILMN UDILT 48 ldx 48 Smp | 2 | Nos. | 31,056 ₹65,528.16 Lowest |
Tender Value
Refer Docs
Closing Date
7 Sept 2026, 10:00 amClosed
THE DIRECTOR
CSIR-IGIB, Mall Road, Delhi-110007
Supply of consumable
2026_CSIR_289343_1
IGIB/2C/37650/26-27(553)
Single
Consumables (Hospital / Lab)
Supply
45 days
CSIR-IGIB, Mall Road, Delhi-110007
Please refer Tender documents.
13 documents required · 13 mandatory
₹0
Exempted
9 Sept 2026
31 Aug 2026
8 Sept 2026
31 Aug 2026
7 Sept 2026
31 Aug 2026
| Sl No | Description | Qty | Unit | Est. Rate | Est. Amount |
|---|---|---|---|---|---|
| 1Supply of the following material: | |||||
| 1.01 | Illumina 5-Base DNA Prep with NovaSeqX 25B (48 Samples) | 1 | Nos. | - | - |
| 1.02 | Illumina® 5-Base DNA Prep (24 Samples) | 2 | Nos. | - | - |
| 1.03 | ILMN UDILT 48 ldx 48 Smp | 2 | Nos. | - | - |
stage.html
html • 0.01 MB
boq_comp_chart.xlsx
xlsx
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Tendernotice_1.pdf
PDF • 1.32 MB
formatt.pdf
Other Document • 2.23 MB
BOQ_337510.xls
BOQ • 0.27 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .